MAGENTIQ-COLO (ME-APDS)

The MAGENTIQ-COLO (ME-APDS) device is a Class II medical device designed to augment video colonoscopy by applying a Computer-Aided Polyp Detection (CADe) engine. Utilizing deep machine learning and advanced algorithms, it processes real-time video to highlight suspicious lesions, demonstrating high recall rates and acceptable false positives in non-clinical testing to assist endoscopists.

The MAGENTIQ-COLO (ME-APDS) device, developed by Magentiq Eye LTD, is a Class II medical device that has received a determination of substantial equivalence to legally marketed predicate devices. This clearance enables its marketing as an adjunct to video colonoscopy procedures, with its primary purpose being to assist endoscopists in the real-time identification of gastrointestinal lesions, such as polyps. Its approval signals its readiness to integrate into clinical practice to enhance lesion detection.The MAGENTIQ-COLO system's core functionality relies on a Computer-Aided Polyp Detection (CADe) engine, which processes video frames from endoscopy cameras using deep machine learning and other algorithms to highlight suspicious areas. Non-clinical testing, encompassing pixel-level image quality comparisons, comprehensive software validation, and electrical and electromagnetic compatibility, confirmed the device's intended function. Standalone performance testing on a large dataset of colonoscopy videos showcased high polyp recall rates (ranging from 97.9% to 90.6%) and acceptable false positive rates, indicating performance comparable to its predecessor.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What are the results of prospective clinical trials evaluating the MAGENTIQ-COLO device's performance in a real-world endoscopy setting with diverse patient populations?; How does the system's performance vary with different colonoscopy equipment, image resolutions, or challenging bowel preparation conditions?; Are there specific polyp morphologies (e.g., flat lesions, sessile serrated lesions) or sizes for which the MAGENTIQ-COLO demonstrates superior or inferior detection capabilities?; What is the potential impact of using this AI-assisted device on endoscopist workload, fatigue, and the overall efficiency of colonoscopy procedures?; Beyond detection, does the MAGENTIQ-COLO system offer capabilities for characterization or risk stratification of identified lesions, and how might this evolve?